GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (MIL:1ILMN) » Definitions » Current Deferred Revenue

Illumina (MIL:1ILMN) Current Deferred Revenue : €228 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Illumina Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Illumina's current deferred revenue for the quarter that ended in Mar. 2024 was €228 Mil.

Illumina Current Deferred Revenue Historical Data

The historical data trend for Illumina's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Current Deferred Revenue Chart

Illumina Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 150.30 152.89 207.09 231.28 231.08

Illumina Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 240.97 230.75 226.75 231.08 228.16

Illumina Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Illumina's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Illumina (MIL:1ILMN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (MIL:1ILMN) » Definitions » Current Deferred Revenue
Comparable Companies
WAT LH DGX ICLR RVTY MTD MEDP CRL NTRA EXAS TMO DHR IQV XSWX:LONN IDXX A SHSE:603259 XPAR:BIM XPAR:ERF QGEN
Traded in Other Exchanges
ILMN:USA ILMN:Mexico ILU:Germany ILMN:Austria
Address
5200 Illumina Way, San Diego, CA, USA, 92122
Website
https://www.illumina.com
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina (MIL:1ILMN) Headlines

No Headlines